Skip to main content
. 2010 May 8;2(2):e2010010. doi: 10.4084/MJHID.2010.010

Table 2:

Transplant-related characteristics

Year of the transplant
1998–2000 8/52 (15%)
2001–2006 44/52 (85%)
Donor
HLA matched sibling 39/52 (75%)
Unrelated or HLA “mismatched” sibling 13/52 (25%)
Source
Bone marrow 18/52 (35%)
Peripheral blood 34/52 (65%)
Conditioning regimen
Fludarabine plus busulphan 14/52 (27%)
Thiotepa plus cyclophosphamide 24/52 (46%)
Fludarabine- 2 Gy TBI 4/52 (8%)
Fludarabine-melphalan 6/52 (11%)
Other 4/52 (8%)